mRNA COVID-19 vaccine: A future hope for cancer treatment
Keywords:Carcinoma, COVID-19, DNA, mRNA, nanoparticles, tumour
Background: mRNA vaccines have a strong potential for a possible cancer therapy platform. They express tumor antigens in antigen-presenting cells (APCs) after immunization, facilitating innate/adaptive immune stimulation. Because of its high effectiveness, safe administration, rapid development potential, and cost-efficient manufacturing, the mRNA cancer vaccine surpasses other traditional vaccination platforms.
Conclusion: Careful evaluation of promising mRNA vaccines to supervise as carriers of lipids for cancer patients needs to be done. In addition, a possible revaluation for optimal protection is required. However, the extent to which solid tumours might take a significant part of the vaccine doses is still unknown.
How to Cite
Copyright (c) 2021 Ajay Kumar Yadav, Suman Gnawali, Sandip Mandal, Gyan Bahadur Shrestha, Gangbiao Yuan
This work is licensed under a Creative Commons Attribution 4.0 International License.